help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 10, 2008
Molecular Endocrinology, doi:10.1210/me.2007-0313
Molecular Endocrinology Vol. 0, No. 2008 200703131-
doi:10.1210/me.2007-0313
Copyright © 2008 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/4/1006    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, M.
Right arrow Articles by Imamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, M.
Right arrow Articles by Imamura, T.

Submitted on June 22, 2007
Accepted on January 3, 2008

{beta}KLOTHO IS REQUIRED FOR FGF21 SIGNALING THROUGH FGFR1c AND FGFR3c

Masashi Suzuki, Yuriko Uehara, Kaori Motomura-Matsuzaka, Junko Oki, Yoshinori Koyama, Miho Kimura, Masahiro Asada, Akiko Komi-Kuramochi, Syuichi Oka, and Toru Imamura*

Signaling Molecules Research Laboratory (M.S., Y.U., K.M.-M., J.O., M.K., M.A., A.K.-K., S.O., T.I.), and Institute for Biological Resources and Functions (Y.K.), National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan

* To whom correspondence should be addressed. E-mail: imamura-toru{at}aist.go.jp.

Fibroblast growth factor (FGF)-21, a structural relative of FGF23 that regulates phosphate homeostasis, is a regulator of insulin-independent glucose transport in adipocytes and plays a role in the regulation of body weight. It also regulates ketogenesis and adaptive responses to starvation. We report that in a reconstituted receptor activation assay system using BaF3 cells, which do not endogenously express any type of FGF receptor (FGFR) or heparan sulfate proteoglycan, FGF21 alone does not activate FGFRs and that {beta}Klotho is required for FGF21 to activate two specific FGFR subtypes: FGFR1c and FGFR3c. Co-expression of {beta}Klotho and FGFR1c on BaF3 cells enabled FGF21, but not FGF23, to activate receptor signaling. Conversely, co-expression of FGFR1c and Klotho, a protein related to {beta}Klotho, enabled FGF23 but not FGF21 to activate receptor signaling, indicating that expression of {beta}Klotho/Klotho confers target cell specificity on FGF21/FGF23. In all of these cases heparin enhanced the activation, but was not essential. In 3T3-L1 adipocytes, upregulation of glucose transporter expression by FGF21 was associated with expression of {beta}Klotho, which was absent in undifferentiated 3T3-L1 fibroblasts. It is thus suggested that {beta}Klotho expression is a crucial determinant of the FGF21 specificity of the target cells upon which it acts in an endocrine fashion.


Key words: FGF21 • {beta}Klotho • FGF receptor • FGFR1c • FGFR3c • glucose transport







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society